Skip Navigation
  • You are viewing a Navigating Care library resource.
  • Go to Library

Treatment of Nodular Lymphocyte–Predominant Hodgkin Lymphoma (NLPHL)

For information about the treatments listed below, see the Treatment Option Overview section.

Treatment of NLPHL in adults may include the following:

  • Watchful waiting or active surveillance.
  • Radiation therapy to the areas of the body with cancer, for patients with early-stage NLPHL.
  • Chemotherapy, for patients with advanced-stage NLPHL.
  • Targeted therapy with a monoclonal antibody (rituximab).
This information is not intended to replace the advice of a doctor. Navigating Care disclaims any liability for the decisions you make based on this information. This information was sourced and adapted from Adapted from the National Cancer Institute's Physician Data Query (PDQ®) Cancer Information Summaries on www.cancer.gov.
This information updated October 1, 2024.

Learn more:

© 2024 Navigating Care, Inc. Patient Engagement Portal v.6.0 | (800) 925-4456 | Privacy Policy | Terms of Use | Certification
This site does not provide medical advice, diagnosis, or treatment.